Results 91 to 100 of about 14,538 (208)

A case of fatal cutaneous caput medusae hemorrhage

open access: yesClinical Case Reports, 2019
Key Clinical Message Alcoholic liver cirrhosis leads to portal venous hypertension, which can result in a caput medusae formation. Life‐threatening hemorrhage from a ruptured caput medusae vein is a rare complication.
Nikolaos Melas   +2 more
doaj   +1 more source

The Role of TIPS in Patients with Refractory Ascites and Portal Vein Thrombosis

open access: yesAnnals of Hepatology, 2017
Nowadays the contraindication for transjugular intrahepatic portosystemic shunt (TIPS) in patients with portal vein thrombosis (PVT) had been modify. The experience and technology have reduce the complications for this procedure.
Paulina Chinchilla-López   +4 more
doaj   +1 more source

Prospective Phase II trial of drug-eluting bead chemoembolization for liver transplant candidates with hepatocellular carcinoma and marginal hepatic reserve. [PDF]

open access: yes, 2019
Purpose: To determine whether chemoembolization using drug-eluting beads (DEB-TACE) is safe and effective for liver transplantation candidates with liver-limited hepatocellular carcinoma (HCC) without vascular invasion and baseline hepatic dysfunction ...
Fidelman, Nicholas   +10 more
core   +1 more source

Portal vein velocity and its dynamics: a potentially useful tool for detecting clinically silent transjugular intrahepatic porto-systemic shunt dysfunction using Doppler ultrasonography

open access: yesUltrasound International Open
Background  Ultrasound (US) surveillance for transjugular intrahepatic portosystemic shunt (TIPS) dysfunction has yet to be standardized, as clear-cut criteria have not been conventionally defined.
Rareș Crăciun   +8 more
doaj   +1 more source

Effect of varenicline on major adverse liver outcomes in alcohol‐associated liver disease: An exploratory analysis

open access: yesAlcohol, Clinical and Experimental Research, Volume 49, Issue 11, Page 2451-2460, November 2025.
This real‐world study assessed whether varenicline improves outcomes in patients with ALD and AUD. Using data from a large electronic health record network, 1278 matched patients were analyzed. Varenicline use was associated with reduced all‐cause mortality and hepatic encephalopathy compared with FDA‐approved AUD therapies (acamprosate or naltrexone),
Pojsakorn Danpanichkul   +10 more
wiley   +1 more source

Utilization of a Pediatric DCD Liver Following Normothermic Regional Perfusion: A Case Report on the Youngest Donor in the United States

open access: yesPediatric Transplantation, Volume 29, Issue 7, November 2025.
ABSTRACT Background Normothermic regional perfusion (NRP) is gaining rapid popularity in adult donation after circulatory death (DCD) to increase organ utilization and improve outcomes. However, literature is lacking for the pediatric population. We therefore present the youngest DCD donor in the United States from whom a liver was recovered with NRP ...
Raphaël M. J. Fischer   +5 more
wiley   +1 more source

Successful Management of Endotipsitis: After Direct Intrahepatic Portocaval Shunt for Budd–Chiari Syndrome

open access: yesJournal of Clinical Interventional Radiology ISVIR
We report successful management of transjugular intrahepatic portosystemic shunt stent infection (endotipsitis) following direct intrahepatic portocaval shunt for chronic Budd–Chiari syndrome. PETCT confirmed FDG-avid vegetation/thrombus within the stent
Nischal G. Kundaragi   +3 more
doaj   +1 more source

Budd-Chiari syndrome treated with direct intrahepatic portocaval shunt: A case report

open access: yesRadiology Case Reports
Budd-Chiari syndrome is an uncommon disorder characterized by occlusion of hepatic veins. It can lead to portal hypertension. Most common causes of this syndrome are hypercoagulability states.
Assim Saad Eddin, MD   +2 more
doaj   +1 more source

Whether Gastrorenal Shunt Embolization Would Benefit the Outcomes of Post Transjugular Intrahepatic Portosystemic Shunt [PDF]

open access: green, 2021
Dongmei Zhao   +5 more
openalex   +1 more source

Home - About - Disclaimer - Privacy